Departments and agencies across the Federal government submitted to OSTP their latest and, in some cases, final, drafts of their scientific integrity policies this past week, in compliance with a deadline I set in October for completion of final or draft-final versions for review.
As a result of that settlement, the drugmaker signed a five-year Corporate Integrity Agreement, which required establishing an internal compliance program and reporting violations, among other things ( read more here).